Fresh analysis suggests that people who come off popular weight-loss injections like Mounjaro or Wegovy tend to recover shed pounds far faster than those who halt conventional lifestyle programs.
Findings released in a major health publication shows that while overweight people can lose substantial amounts of their total mass while on the medication, the weight is regained at an average rate of 0.8 kg per month after stopping.
"People purchasing such treatments need to be informed of the potential of fast rebound weight gain when the medication ends," stated researcher Dr. Susan Jebb.
Such speed of recovery implies a reversion to original weight within about one and a half years.
Weighing Approaches
The analysis, which looked at dozens of studies involving over 9,000 of patients, contrasted the effects of the injectable medications with conventional dieting.
The team note that individuals who shed pounds through diet and exercise typically have a less rapid creep back—perhaps 0.1 kg a month—once they finish.
Understanding the Quick Rebound
Doctors believe the mode of action of the jabs accounts for the accelerated weight return.
These medications mimic a body's own chemical called glucagon-like peptide-1, which moderates appetite.
"Artificially providing GLP-1 concentrations several times higher than the body's typical production might result in the system to produce less of its own natural hormone, and may also reduce sensitivity to its effects," said Dr. Adam Collins, a nutrition expert.
"Stopping of this GLP-1 'fix' leads to hunger is unsuppressed, making binge eating a significant risk."
A Lifelong Disease?
The NHS recommend the jabs for people with obesity-related health risks, accompanied by prescribed diet and exercise modifications.
Professionals argue that, considering the high risk of relapse, the treatment should be considered long-term.
This opinion is reinforced by drug manufacturers, who state that the findings "underscore the persistent nature of obesity," similar to managing conditions like diabetes.
User Accounts
Individuals who have come off the jabs explain a intense resurgence of hunger.
"I experienced a trigger flipping and you become ravenous," said one woman.
The struggle is compounded if users have not developed permanent lifestyle or habit modifications during therapy.
Widespread Interest
Survey data suggest that a significant number of people in the UK have tried weight-loss jabs in the past year, with desire remaining high.
- Adoption is more common among females compared to men.
- The 40s and 50s demographic shows the greatest level of interest.
- Many obtain the medications through private prescriptions rather than the NHS.
In conclusion, experts caution that while the jabs are potent tools for weight loss, they are not a permanent solution and lasting health benefits relies on combined behavioural management.
